Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 40Leukemia, Myelogenous, Chronic, BCR-ABL Positive 32Leukemia 17Leukemia, Myeloid, Chronic-Phase 16Leukemia, Myeloid, Acute 14Breast Neoplasms 12Recurrence 11Leukemia, Lymphocytic, Chronic, B-Cell 10Prostatic Neoplasms 9Neoplasm Metastasis 9Carcinoma, Non-Small-Cell Lung 9Lung Neoplasms 7Blast Crisis 7Pancreatic Neoplasms 6Burkitt Lymphoma 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Neoplasms 5Multiple Myeloma 5Lymphoma, Non-Hodgkin 5Glioma 5Glioblastoma 5Philadelphia Chromosome 4Myelodysplastic Syndromes 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma 4Leukemia, Myeloid, Accelerated Phase 4Gliosarcoma 4Gastrointestinal Stromal Tumors 4Colorectal Neoplasms 4Waldenstrom Macroglobulinemia 3

Interventions

etoposide phosphate 1enzalutamide 1Tissue Banks 1Temozolomide 1Radiotherapy 1Radiation 1Patient Discharge 1Etoposide 1Dasatinib 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Brain Diseases × Dasatinib × Clear all
NCT00895960 2018-11-08

Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma

M.D. Anderson Cancer Center

Phase 1 Terminated
16 enrolled
CNSSarcoma

Brain Diseases, Central Nervous System Diseases, Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡